Targeted stem cells cut fractures by 94% in small osteoporosis trial

In a first-in-human trial, 10 women over 50 with advanced osteoporosis received one IV infusion of their own engineered bone marrow stem cells. Over two years, fractures fell from eight per year to 0.5 across the group, with bone tissue gains and less pain reported.